Lapix Therapeutics operates as an immune system modulation company.
Lapix Therapeutics has raised $5.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in August 2024.
Lapix Therapeutics is headquartered in Boston, United States.
Lapix Therapeutics operates as an immune system modulation company.
Lapix Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Lapix Therapeutics — Funding & Investors." VCBacked, August 16, 2024, https://www.vcbacked.co/company/lapix-therapeutics. Accessed November 11, 2026.
VCBacked. (2024). Lapix Therapeutics — Funding & Investors. Retrieved November 11, 2026, from https://www.vcbacked.co/company/lapix-therapeutics
{{cite web |title=Lapix Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/lapix-therapeutics |website=VCBacked |access-date=November 11, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Lapix Therapeutics? Request a listing update